Recruiting OBSERVATIONAL NCT06756022
Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
Prospective, Multicenter, Real-world Study of Dolasetron Mesylate Injection for the Prevention of Chemotherapy-induced Nausea and Vomiting in Children With Acute Lymphoblastic Leukemia
Sponsor: Anhui Provincial Children's Hospital
Conditions
Chemotherapy Induced Nausea and Vomiting
Interventions
Dolasetron mesylate injection
Updated 1 time since 2025 Last updated: Dec 30, 2024 Started: Nov 21, 2024 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Chemotherapy Induced Nausea and Vomiting, this trial is actively recruiting participants. The trial is conducted by Anhui Provincial Children's Hospital and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Anhui Provincial Children's Hospital
Data source: Anhui Provincial Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .